Quantoom Biosciences is on a mission to remove the barriers to making mRNA-based vaccines & therapeutics, at every stage from sequence up to mass production. In the BAXERNA project, Quantoom will use its expertise in affordable manufacturing technologies to evaluate candidate vaccine formulations.